Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03955783
Brief Title: Venetoclax and Selinexor in Treating Patients With Relapsed or Refractory High Risk Hematologic Malignancies

First Submitted : May 16, 2019
First Submitted that Met QC Criteria : May 16, 2019
First Posted : May 20, 2019

Last Update Submitted that Met QC Criteria : June 27, 2019
Last Update Posted : July 1, 2019